Number of patient samples tested by each technique and at each time point
| Technique . | No. of patients . | No. of samples . | ||
|---|---|---|---|---|
| Diagnosis . | Relapse . | Both time points . | ||
| Mutation screening | 47 | 22 | 26 | 1 |
| Methylation status | 99 | 73 | 29 | 3 |
| SNP array | 98 | 86 | 20 | 8 |
| Array CGH | 105 | 103 | 3 | 1 |
| FISH | 1171 | 1130 | 77 | 36 |
| Technique . | No. of patients . | No. of samples . | ||
|---|---|---|---|---|
| Diagnosis . | Relapse . | Both time points . | ||
| Mutation screening | 47 | 22 | 26 | 1 |
| Methylation status | 99 | 73 | 29 | 3 |
| SNP array | 98 | 86 | 20 | 8 |
| Array CGH | 105 | 103 | 3 | 1 |
| FISH | 1171 | 1130 | 77 | 36 |
SNP indicates single nucleotide polymorphism; CGH, comparative genomic hybridization; and FISH, fluorescence in situ hybridization.